| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
APRE
Aprea Therapeutics
|
Aug 10, 2026 | BUY |
Buy
+3422.0% avg upside
7 analysts
|
$1.20
79.13% Upside
|
· | · |
|
CLNN
Clene
|
Aug 10, 2026 | BUY |
Strong Buy
+552.4% avg upside
11 analysts
|
$31.00
582.81% Upside
|
-15.3% | · |
|
ATYR
aTyr Pharma
|
Aug 10, 2026 | HOLD |
Buy
+1492.9% avg upside
17 analysts
|
— | · | · |
|
ATNM
Actinium Pharmaceuticals
|
Aug 10, 2026 | BUY |
Strong Buy
+878.9% avg upside
11 analysts
|
$4.00
419.49% Upside
|
· | · |
|
LCTX
Lineage Therap
|
Aug 07, 2026 | BUY |
Strong Buy
+389.7% avg upside
16 analysts
|
$9.00
689.40% Upside
|
+0.0% | · |
|
CLDX
Celldex
|
Aug 07, 2026 | BUY |
Strong Buy
-4.1% avg upside
28 analysts
|
$42.00
1.28% Downside
|
+0.0% | · |
|
OABI
OmniAb
|
Aug 07, 2026 | BUY |
Strong Buy
+133.4% avg upside
10 analysts
|
$11.00
228.34% Upside
|
+0.0% | · |
|
LGND
Ligand Pharma
|
Aug 07, 2026 | BUY |
Strong Buy
-6.9% avg upside
15 analysts
|
$358.00
23.24% Upside
|
+0.0% | · |
|
CYTK
Cytokinetics
|
Aug 07, 2026 | BUY |
Strong Buy
+16.0% avg upside
36 analysts
|
$140.00
82.29% Upside
|
+0.9% | · |
|
IOVA
Iovance Biotherapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+106.6% avg upside
24 analysts
|
$9.00
39.04% Upside
|
+4.5% | · |
|
TNYA
Tenaya Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+1259.7% avg upside
11 analysts
|
$3.00
315.05% Upside
|
+2.7% | · |
|
BMEA
Biomea Fusion
|
Aug 06, 2026 | BUY |
Strong Buy
+946.6% avg upside
15 analysts
|
$4.00
218.81% Upside
|
+0.8% | · |
|
EWTX
Edgewise Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+3.5% avg upside
15 analysts
|
$45.00
3.70% Upside
|
+0.6% | · |
|
NAMS
NewAmsterdam Pharma Company
|
Aug 06, 2026 | BUY |
Strong Buy
+70.4% avg upside
19 analysts
|
$52.00
86.80% Upside
|
+1.1% | · |
|
CMPX
Compass Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+340.1% avg upside
20 analysts
|
$24.00
1026.83% Upside
|
+10.8% | · |
|
LXRX
Lexicon Pharmaceuticals
|
Aug 06, 2026 | BUY |
Buy
+64.8% avg upside
9 analysts
|
$6.00
144.32% Upside
|
+4.7% | · |
|
RIGL
Rigel
|
Aug 05, 2026 | BUY |
Strong Buy
-40.9% avg upside
17 analysts
|
$57.00
39.08% Upside
|
+2.9% | · |
|
QTTB
Q32 Bio
|
Aug 05, 2026 | BUY |
Buy
+280.8% avg upside
24 analysts
|
$36.00
127.84% Upside
|
-5.4% | · |
|
TVTX
Travere Therapeutics
|
Aug 05, 2026 | BUY |
Strong Buy
-8.0% avg upside
22 analysts
|
$67.00
8.91% Upside
|
-1.8% | · |
|
NVCT
Nuvectis Pharma
|
Aug 04, 2026 | BUY |
Strong Buy
+55.7% avg upside
6 analysts
|
$39.00
107.31% Upside
|
-5.8% | · |
|
ANL
Adlai Nortye Ltd. Sponsored ADR
|
Aug 03, 2026 | BUY |
Strong Buy
+63.8% avg upside
7 analysts
|
$20.00
52.34% Upside
|
+2.2% | · |
|
KRYS
Krystal Biotech
|
Aug 03, 2026 | BUY |
Strong Buy
-21.8% avg upside
19 analysts
|
$361.00
10.75% Upside
|
+4.4% | · |
|
CAPR
Capricor Therapeutics
|
Jul 30, 2026 | HOLD |
Buy
+232.8% avg upside
12 analysts
|
— | -8.8% | · |
|
PHAR
Pharming Group
|
Jul 30, 2026 | BUY |
Strong Buy
+248.0% avg upside
4 analysts
|
$37.00
239.51% Upside
|
+1.9% | · |
|
VKTX
Viking Therapeutics
|
Jul 30, 2026 | BUY |
Strong Buy
+109.0% avg upside
31 analysts
|
$102.00
199.27% Upside
|
+2.9% | · |
|
CALC
CalciMedica
|
Jul 29, 2026 | HOLD |
Buy
+4116.3% avg upside
9 analysts
|
— | -7.4% | · |
|
KURA
Kura Oncology
|
Jul 27, 2026 | BUY |
Strong Buy
+166.2% avg upside
26 analysts
|
$40.00
316.24% Upside
|
-2.2% | · |
|
KAPA
Kairos Pharma, Ltd.
|
Jul 27, 2026 | BUY |
Strong Buy
+2903.0% avg upside
4 analysts
|
$12.00
3228.63% Upside
|
+24.5% | · |
|
AU:BOT
Botanix Pharmaceuticals Limited
|
Jul 27, 2026 | BUY |
Strong Buy
+4247.8% avg upside
1 analyst
|
$1.00
4247.82% Upside
|
+9.5% | · |
|
NEUP
Neuphoria Therapeutics
|
Jul 27, 2026 | HOLD |
Strong Buy
+420.1% avg upside
6 analysts
|
— | -0.8% | · |
|
ANAB
AnaptysBio
|
Jul 21, 2026 | BUY |
Strong Buy
+29.8% avg upside
26 analysts
|
$95.00
69.08% Upside
|
+3.2% | · |
|
CVKD
Cadrenal Therapeutics, Inc.
|
Jul 21, 2026 | BUY |
Strong Buy
+1398.3% avg upside
2 analysts
|
$13.00
577.07% Upside
|
-10.1% | · |
|
ARMP
Armata Pharmaceuticals
|
Jul 20, 2026 | BUY |
Strong Buy
+203.2% avg upside
4 analysts
|
$15.00
222.63% Upside
|
-7.1% | · |
|
GUTS
Fractyl Health, Inc.
|
Jul 15, 2026 | BUY |
Strong Buy
+570.9% avg upside
7 analysts
|
$8.00
1047.23% Upside
|
-23.1% | · |
|
FR:ALSEN
Sensorion SAS
|
Jun 10, 2026 | HOLD |
Strong Buy
+415.0% avg upside
6 analysts
|
— | +2.1% | · |
|
STTK
Shattuck Labs
|
Jun 09, 2026 | BUY |
Strong Buy
+204.8% avg upside
15 analysts
|
$18.00
149.73% Upside
|
+70.3% | · |
|
BCDA
BioCardia
|
Jun 09, 2026 | BUY |
Strong Buy
+1519.0% avg upside
5 analysts
|
$25.00
2517.36% Upside
|
+14.0% | · |
|
LSTA
Lisata Therapeutics
|
May 18, 2026 | HOLD |
Buy
+1126.3% avg upside
11 analysts
|
— | -66.0% | · |
|
PROK
ProKidney
|
May 18, 2026 | BUY |
Buy
+296.2% avg upside
12 analysts
|
$12.00
627.27% Upside
|
+1.9% | · |
|
PDSB
PDS Biotechnology
|
May 14, 2026 | BUY |
Strong Buy
+1983.4% avg upside
11 analysts
|
$15.00
1954.77% Upside
|
-45.8% | · |
|
TPST
Tempest Therapeutics
|
Mar 31, 2026 | BUY |
Buy
+2014.7% avg upside
18 analysts
|
$11.00
909.12% Upside
|
-44.1% | · |
|
PHGE
BiomX
|
Mar 09, 2026 | HOLD |
Buy
+15051.5% avg upside
4 analysts
|
— | -97.7% | · |
|
FBIO
Fortress Biotech
|
Feb 23, 2026 | BUY |
Strong Buy
+193.0% avg upside
12 analysts
|
$17.00
535.45% Upside
|
-19.7% | · |
|
YARW
Yarrow Bioscience
|
Dec 17, 2025 | HOLD |
Strong Buy
-34.1% avg upside
9 analysts
|
— | +122.6% | · |
|
SE:MVIR
Medivir AB
|
Oct 23, 2025 | BUY |
Strong Buy
+2173.6% avg upside
2 analysts
|
$54.00
2867.04% Upside
|
+239.9% | · |
|
BLRX
Bioline RX Ltd Sponsored ADR
|
Aug 14, 2025 | BUY |
Strong Buy
+261.5% avg upside
6 analysts
|
$26.00
866.50% Upside
|
-28.1% | · |
|
XBIO
Xenetic Biosciences
|
Aug 13, 2025 | HOLD |
Hold
2 analysts
|
— | +6.0% | · |
|
TSE:SVA
Sernova
|
Jul 09, 2025 | BUY |
Strong Buy
+3374.1% avg upside
3 analysts
|
$6.00
5614.24% Upside
|
-25.0% | · |
|
GNTA
Genenta Science SpA Sponsored ADR
|
Jul 02, 2025 | BUY |
Strong Buy
+1100.3% avg upside
3 analysts
|
$25.00
1808.42% Upside
|
-66.4% | · |
|
PTN
Palatin Technologies
|
Jun 20, 2025 | HOLD |
Strong Buy
+1400.7% avg upside
4 analysts
|
— | -2.9% | · |
|
DE:MDG1
Medigene
|
Apr 08, 2025 | HOLD |
Buy
+79900.1% avg upside
2 analysts
|
— | · | · |
|
BIORQ
Biora Therapeutics
|
Mar 31, 2025 | HOLD |
Buy
+269249900.0% avg upside
6 analysts
|
— | · | · |
|
BPTSY
Biophytis
|
Feb 26, 2025 | HOLD |
Sell
+24.7% avg upside
2 analysts
|
— | -91.0% | · |
|
BRRGF
Oncoinvent ASA
|
Feb 26, 2025 | HOLD |
Hold
1 analyst
|
— | · | · |
|
TRAW
Traws Pharma
|
Sep 25, 2024 | HOLD |
Buy
+5736.3% avg upside
10 analysts
|
— | -92.5% | · |
|
PBLA
Panbela Therapeutics
|
Sep 25, 2024 | HOLD |
Buy
+4504404.5% avg upside
3 analysts
|
— | · | · |
|
MBIO
Mustang Bio
|
May 16, 2024 | BUY |
Strong Buy
+1042.5% avg upside
5 analysts
|
$2.00
233.35% Upside
|
-96.0% | · |
|
GB:OXB
Oxford BioMedica
|
Nov 29, 2023 | HOLD |
Strong Buy
+76.8% avg upside
4 analysts
|
— | +266.3% | · |
|
IMVIF
IMV
|
Aug 08, 2023 | HOLD |
Buy
+2454402850.0% avg upside
7 analysts
|
— | · | · |
|
XNCR
Xencor
|
Aug 07, 2023 | HOLD |
Strong Buy
+62.3% avg upside
27 analysts
|
— | -69.8% | · |
|
HURA
TuHURA Biosciences
|
Feb 09, 2023 | HOLD |
Strong Buy
+328.5% avg upside
8 analysts
|
— | · | · |
|
GNCAQ
Genocea Biosciences
|
Apr 29, 2022 | HOLD |
Strong Buy
+573999900.0% avg upside
10 analysts
|
— | · | · |
|
BYSI
Beyondspring
|
Apr 14, 2022 | HOLD |
Hold
+926.2% avg upside
8 analysts
|
— | -4.6% | · |
|
PVLA
Palvella Therapeutics
|
Nov 02, 2021 | BUY |
Strong Buy
+10.1% avg upside
27 analysts
|
$9.00
94.12% Downside
|
-94.5% | · |
|
SSKN
Strata Skin Sciences
|
Aug 23, 2021 | BUY |
Strong Buy
+85199900.0% avg upside
5 analysts
|
$3.00
2999899.94% Upside
|
-55.5% | · |
|
GB:0RIS
Targovax ASA
|
Aug 18, 2021 | BUY |
Strong Buy
+38.1% avg upside
1 analyst
|
$12.18
38.15% Upside
|
· | · |
|
NL:PHARM
Pharming Group
|
Aug 05, 2021 | BUY |
Strong Buy
+247.0% avg upside
4 analysts
|
$3.10
225.95% Upside
|
+24.1% | · |
|
AU:PTX
Prescient Therapeutics Limited
|
Nov 27, 2019 | HOLD |
Hold
1 analyst
|
— | · | · |
|
IRD
Opus Genetics
|
Aug 07, 2019 | HOLD |
Strong Buy
+184.5% avg upside
25 analysts
|
$3.00
19.20% Downside
|
-52.4% | · |
|
OTLC
Oncotelic Therapeutics
|
Apr 22, 2019 | HOLD |
Strong Buy
+10717.9% avg upside
5 analysts
|
— | +222.2% | · |
|
SCPX
Scorpius Holdings
|
Nov 16, 2018 | BUY |
Strong Buy
+1525941.6% avg upside
11 analysts
|
$6.00
499899.97% Upside
|
· | · |
|
SLS
SELLAS Life Sciences Group
|
Jul 31, 2018 | BUY |
Strong Buy
+522.0% avg upside
16 analysts
|
$4.00
65.47% Downside
|
-93.8% | · |
|
SNGX
Soligenix
|
Mar 16, 2018 | HOLD |
Buy
+767.4% avg upside
6 analysts
|
$2.70
594.26% Upside
|
· | · |
|
RBSH
Rebus Holdings
|
Jun 02, 2017 | BUY |
Strong Buy
+1999900.0% avg upside
2 analysts
|
— | · | · |
|
IMNN
Imunon
|
Apr 10, 2017 | BUY |
Strong Buy
+803.0% avg upside
11 analysts
|
$21.00
1212.55% Upside
|
· | · |
|
TGTX
TG Therapeutics
|
Dec 07, 2016 | BUY |
Strong Buy
-10.5% avg upside
20 analysts
|
$33.00
32.98% Downside
|
-2.9% | · |
|
VSTM
Verastem
|
Dec 07, 2016 | HOLD |
Strong Buy
+126.2% avg upside
24 analysts
|
$2.00
69.24% Downside
|
+276.3% | · |
|
SRNE
Sorrento Therapeutics
|
Dec 05, 2016 | BUY |
Strong Buy
+6145733.3% avg upside
7 analysts
|
$15.00
3749899.95% Upside
|
· | · |
|
ENLV
Enlivex
|
Nov 29, 2016 | BUY |
Strong Buy
+2001.6% avg upside
4 analysts
|
$15.00
624.69% Upside
|
· | · |
|
NTBLQ
Notable Labs
|
Nov 29, 2016 | BUY |
Buy
+809999900.0% avg upside
12 analysts
|
$17.00
1699999900.09% Upside
|
· | · |
|
IMMP
Immutep
|
Nov 28, 2016 | BUY |
Strong Buy
+1305.0% avg upside
7 analysts
|
$6.00
1457.22% Upside
|
-1.2% | · |
|
PALI
Palisade Bio
|
Nov 28, 2016 | BUY |
Strong Buy
+1130.8% avg upside
16 analysts
|
$15.60
655.53% Upside
|
· | · |
|
IMUC
ImmunoCellular Therapeutics
|
Nov 23, 2016 | BUY |
Strong Buy
+2400.0% avg upside
3 analysts
|
$8.00
3536.42% Upside
|
· | · |
|
CFRXQ
ContraFect
|
Nov 09, 2016 | HOLD |
Buy
+10969999900.0% avg upside
10 analysts
|
$2.20
219999899.98% Upside
|
· | · |
|
REGN
Regeneron
|
Oct 31, 2016 | BUY |
Strong Buy
-2.3% avg upside
58 analysts
|
$520.00
35.31% Downside
|
-1.7% | · |
|
DARE
Daré Bioscience
|
Oct 18, 2016 | BUY |
Strong Buy
+883.4% avg upside
14 analysts
|
$2.50
82.48% Upside
|
· | · |
|
DCOY
Decoy Therapeutics
|
Sep 13, 2016 | BUY |
Strong Buy
+584.8% avg upside
7 analysts
|
$26.00
575.30% Upside
|
· | · |
|
CNSY
Cerenome
|
Jun 27, 2016 | BUY |
Strong Buy
+732.4% avg upside
11 analysts
|
$11.00
182.86% Upside
|
· | · |
|
CRIS
Curis
|
Feb 29, 2016 | BUY |
Strong Buy
+245.2% avg upside
12 analysts
|
$5.00
32.32% Upside
|
· | · |
|
TLOG
Tetralogic Pharma
|
Jan 07, 2016 | BUY |
Strong Buy
+433333233.3% avg upside
3 analysts
|
$1.00
99999900.00% Upside
|
· | · |
|
MDGL
Madrigal Pharmaceuticals
|
Oct 21, 2015 | HOLD |
Strong Buy
-2.2% avg upside
33 analysts
|
$35.00
93.13% Downside
|
+73.8% | · |
|
CANF
Can-Fite BioPharma
|
May 31, 2015 | HOLD |
Strong Buy
+56.8% avg upside
8 analysts
|
$3.30
1.42% Downside
|
· | · |
|
LITS
Lite Strategy
|
Mar 23, 2015 | HOLD |
Buy
+1154.7% avg upside
13 analysts
|
$2.50
192.76% Upside
|
· | · |
|
LADX
LadRx
|
Sep 30, 2013 | BUY |
Strong Buy
+64445.5% avg upside
5 analysts
|
$9.00
81718.21% Upside
|
· | · |
|
AGEN
Agenus
|
Nov 09, 2012 | BUY |
Strong Buy
+32.6% avg upside
18 analysts
|
— | · | · |
|
AMRN
Amarin
|
Sep 11, 2012 | BUY |
Buy
-40.5% avg upside
18 analysts
|
$26.00
82.38% Upside
|
-86.7% | · |
|
MBOT
Microbot Medical
|
Jul 24, 2012 | BUY |
Strong Buy
+249.1% avg upside
7 analysts
|
$5.00
158.98% Upside
|
· | · |
|
BGMS
Bio Green Med Solution
|
Feb 04, 2010 | BUY |
Strong Buy
+1379.1% avg upside
7 analysts
|
$7.00
700.88% Upside
|
· | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.